New Technology Reduces Coal Power Emissions to Natural Gas Levels and Reduces CO2 By Up To 40%

FuturEnergy Files Revolutionary Patent Utilizing MagneGas® Fuel in Coal Co-Combustion Process Producing Energy While Reducing Greenhouse Gases

TOOWOOMBA, Australia, Oct. 9, 2014 -- FuturEnergy Pty Ltd, an Australian based combustion research and development Company, announced today that it has submitted a pioneer patent, on combusting coal emissions containing CO2 in a secondary post combustion chamber with MagneGas® fuel.  The patent, 'Utilising synergistic mixture of fuel to produce energy and reduce emissions in boilers,' was filed with the Australian patent office on 30th July 2014.

Read more: MagneGas Corporation ( MNGA )

The Traders Podcast with Rob Booker

Returning to a more typical and positive vibe, Episode 285 of The Traders Podcast features your host Rob Booker and Jason the producer talking about some of their favorite quotations. Rob relates these quotes to trading, naturally. Rob asserts that people generally do what they want to do, regardless of their reasons given.

Rob reads a quote from a forthcoming trading book by Shonn Campbell called FX Inventory, which encourages traders to be free from the burden of false precision. He cites another portion of the book that suggests that trading is about playing offense and defense at the same time. Rob also asserts that your ability to make money is directly proportional to your ability to calm the hell down. Rob says that dramatic people make the worst traders. And we conclude this episode with a voicemail from actor Morgan Freeman, who tries his hand at reciting The Traders Podcast intro! Thanks for listening.

[ Listen to The Podcast ]

Integra Gold Announces Additional High Grade Results at Triangle With 31.9 g/t Gold Over 3.0 Meters, 38.6 g/t Gold Over 2.3 Meters and 38.8 g/t Gold Over 2.0 Meters

Intercepts Continue to Confirm and Expand Lateral and Down-Dip Continuity of Known Mineralized Zones at Triangle

VANCOUVER, BC-- - Integra Gold Corp. (TSX VENTURE: ICG) ("Integra" or the "Company") is pleased to announce additional results from its 2014 Triangle Zone definition and extension drill program at the Lamaque Gold Project ("Lamaque") located in Val-d'Or, Québec.

The Company completed 25,040 meters ("m") of drilling in 65 drill holes as part of its 2014 winter drill program at the high-grade Triangle Zone. The results announced today are from 16 holes, representing 6,295 m of the program.

Read more: Integra Gold Corp (ICG )

PyroGenesis Signs $12.5MM Contract for the Sale of Powder Production Systems for 3D Printing with International Large-Scale Manufacturer; Backlog now exceeds $20 Million

MONTREAL, July 7, 2014 - PyroGenesis Canada Inc. (http://pyrogenesis.com) (TSXV:PYR.V - News), a TSX Venture 50® plasma solutions company that designs, develops and manufactures plasma waste-to-energy systems and plasma torch systems, announced today that it has signed a contract with a major international  manufacturer (the 'Customer') for ten plasma-based, powder production systems for 3D printing. The contract is for the supply by PyroGenesis of ten of its unique metal powder production platforms to the Customer over an 18-month period for a contract value of $12.5 MM. The Customer's name is being withheld for competitive reasons.

Read more: PyroGenesis Canada Inc ( PYR )

Genetic Technologies Provides BREVAGen(TM) Revenue Update for Quarter Ending June 30, 2014

MELBOURNE, AUSTRALIA---  Molecular diagnostics company Genetic Technologies Limited (ASX: GTG) (NASDAQ: GENE) is pleased to announce that the number of BREVAGen™ test samples received during the quarter ended June 30, 2014 returned to levels achieved in late CY13. Total patient samples received during the quarter were 1,096, representing 37% growth over the March 2014 quarter (800 samples).

As mentioned in previous communications, the start of CY14 brought severe winter weather across large parts of the U.S. and this restricted patient and physician physical access to medical centers and willingness to attend for anything other than urgent medical care. Further to this challenge, the holiday period coincided with the introduction of the Affordable Care Act under ObamaCare, which created uncertainty in patients' understanding of their out of pocket expense liability that also restricted the uptake of BREVAGen. With these factors removed, the Company saw a return of patients to doctors' offices and improved preparedness to make preventive care decisions.

Read more: Genetic Technologies Limited ( GENE )